FDA Approves New Mucinex 12HR Multi-Symptom Cold and Fever Medication

Reckitt announced that the U.S. FDA has approved Mucinex 12HR Cold & Fever Multi-Symptom. This marks the first over-the-counter innovation in the cold and flu category in 14 years, offering consumers a new option. The medication is approved to treat fever, cough, chest congestion, and body pain for 12 hours, providing extended symptom relief.